0001250853-14-000075.txt : 20140516 0001250853-14-000075.hdr.sgml : 20140516 20140516203351 ACCESSION NUMBER: 0001250853-14-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140515 FILED AS OF DATE: 20140516 DATE AS OF CHANGE: 20140516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lion Biotechnologies, Inc. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO [4731] IRS NUMBER: 753254381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21900 BURBANK BLVD. STREET 2: THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 BUSINESS PHONE: 818-992-3126 MAIL ADDRESS: STREET 1: 21900 BURBANK BLVD. STREET 2: THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Handelman Michael D CENTRAL INDEX KEY: 0001299390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53127 FILM NUMBER: 14853047 MAIL ADDRESS: STREET 1: 21900 BURBANK BLVD, THIRD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-05-15 0 0001425205 Lion Biotechnologies, Inc. LBIO 0001299390 Handelman Michael D 21900 BURBANK BLVD, THIRD FLOOR WOODLAND HILLS CA 91367 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 7.95 2014-05-15 4 A 0 75000 0 A 2019-05-14 Common Stock 75000 75000 D Restricted Stock Units 0 2014-05-15 4 A 0 75000 0 A Common Stock 75000 75000 D The option will vest as to 25,000 shares on May 15, 2015 and the remaining shares shall vest in equal quarterly installments over the next two years following May 15, 2015, provided the Reporting Person remains in continuous employ of the Issuer. The option will vest as to (i) 25,000 shares on May 15, 2015, provided, however, that this vesting date will accelerate and change to August 15, 2014 if the Issuer has timely filed the quarterly reports of Form 10-Q for the fiscal quarters ended March 31, 2014 and June 30, 2014 and (ii) 25,000 shares shall vest on each of May 15, 2016 and May 15, 2017, provided the Reporting Person remains in continuous employ of the Issuer. /s/ Michael Handelman 2014-05-16